MediWound plans to price initial public offering of its ordinary stock

Credit Suisse, Jefferies and BMO Capital Markets are the bookrunners

By Devika Patel

Knoxville, Tenn., Feb. 10 - MediWound Ltd. will conduct an initial public offering of its ordinary stock with a 30-day greenshoe, according to an F-1 filed Monday with the Securities and Exchange Commission.

Credit Suisse Securities (USA) LLC, Jefferies LLC and BMO Capital Markets Corp. are the joint bookrunning managers. Piper Oppenheimer & Co. Inc. is the co-manager.

Proceeds will be used for sales and marketing, research and development, expanding manufacturing capabilities and for other general corporate purposes.

The biopharmaceutical company is based in Yavne, Israel. The company intends to list its common stock on the Nasdaq stock exchange under the symbol "MDWD."

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.